Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey Conn

Showing results (61-70 of 416) with videos related to

Pageof 42
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2015
Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent CationsBrian Dean, Shaun Hopper, P Jeffrey Conn, et al.
Neuropharmacology|August 12, 2020
Contrasting sex-dependent adaptations to synaptic physiology and membrane properties of prefrontal cortex interneuron subtypes in a mouse model of binge drinkingMax E Joffe, Danny G Winder, P Jeffrey Conn
Molecular Pharmacology|December 7, 2007
N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptorsYelin Chen, Cyril Goudet, Jean-Philippe Pin, et al.
Molecular Interventions|April 12, 2008
Schizophrenia: moving beyond monoamine antagonistsP Jeffrey Conn, Carol Tamminga, Darryle D Schoepp, et al.
Neuropharmacology|March 20, 2012
Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptorsShen Yin, Rocio Zamorano, P Jeffrey Conn, et al.
Nature Reviews. Neuroscience|November 9, 2005
Metabotropic glutamate receptors in the basal ganglia motor circuitP Jeffrey Conn, Giuseppe Battaglia, Michael J Marino, et al.
Neuropharmacology|July 20, 2010
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potentialKaren J Gregory, Elizabeth N Dong, Jens Meiler, et al.
Nature Reviews. Drug Discovery|September 2, 2014
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disordersP Jeffrey Conn, Craig W Lindsley, Jens Meiler, et al.
ACS Chemical Neuroscience|April 2, 2019
Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine PathwaySamantha E Yohn, Jordan Galbraith, Erin S Calipari, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activityRuggero Galici, Nicholas G Echemendia, Alice L Rodriguez, et al.
Pageof 42

Showing results (61-70 of 416) with videos related to

Sort By:
Pageof 42
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 30, 2015
Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent CationsBrian Dean, Shaun Hopper, P Jeffrey Conn, et al.
Neuropharmacology|August 12, 2020
Contrasting sex-dependent adaptations to synaptic physiology and membrane properties of prefrontal cortex interneuron subtypes in a mouse model of binge drinkingMax E Joffe, Danny G Winder, P Jeffrey Conn
Molecular Pharmacology|December 7, 2007
N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptorsYelin Chen, Cyril Goudet, Jean-Philippe Pin, et al.
Molecular Interventions|April 12, 2008
Schizophrenia: moving beyond monoamine antagonistsP Jeffrey Conn, Carol Tamminga, Darryle D Schoepp, et al.
Neuropharmacology|March 20, 2012
Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptorsShen Yin, Rocio Zamorano, P Jeffrey Conn, et al.
Nature Reviews. Neuroscience|November 9, 2005
Metabotropic glutamate receptors in the basal ganglia motor circuitP Jeffrey Conn, Giuseppe Battaglia, Michael J Marino, et al.
Neuropharmacology|July 20, 2010
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potentialKaren J Gregory, Elizabeth N Dong, Jens Meiler, et al.
Nature Reviews. Drug Discovery|September 2, 2014
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disordersP Jeffrey Conn, Craig W Lindsley, Jens Meiler, et al.
ACS Chemical Neuroscience|April 2, 2019
Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine PathwaySamantha E Yohn, Jordan Galbraith, Erin S Calipari, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activityRuggero Galici, Nicholas G Echemendia, Alice L Rodriguez, et al.
Pageof 42